Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Neoplasms | 10 | 2015 | 22 | 2.460 |
Why?
|
| Spinal Cord Neoplasms | 6 | 2013 | 12 | 2.060 |
Why?
|
| Fetal Proteins | 4 | 2016 | 7 | 1.760 |
Why?
|
| T-Box Domain Proteins | 4 | 2016 | 14 | 1.750 |
Why?
|
| Chordoma | 6 | 2016 | 7 | 1.730 |
Why?
|
| Neurosurgical Procedures | 8 | 2018 | 94 | 1.290 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2016 | 10 | 0.920 |
Why?
|
| Thoracic Vertebrae | 3 | 2015 | 39 | 0.800 |
Why?
|
| Humans | 46 | 2020 | 32284 | 0.670 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2015 | 61 | 0.660 |
Why?
|
| Back Pain | 1 | 2020 | 26 | 0.640 |
Why?
|
| Atlanto-Occipital Joint | 2 | 2010 | 4 | 0.640 |
Why?
|
| Cannabinoids | 1 | 2020 | 56 | 0.620 |
Why?
|
| Stereotaxic Techniques | 3 | 2010 | 23 | 0.610 |
Why?
|
| Cervical Vertebrae | 4 | 2015 | 50 | 0.610 |
Why?
|
| Cell Line, Tumor | 5 | 2016 | 729 | 0.600 |
Why?
|
| Spinal Fusion | 5 | 2014 | 52 | 0.590 |
Why?
|
| Preoperative Care | 2 | 2011 | 125 | 0.590 |
Why?
|
| Lumbar Vertebrae | 4 | 2019 | 97 | 0.580 |
Why?
|
| Brain Abscess | 1 | 2018 | 3 | 0.560 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2018 | 5 | 0.560 |
Why?
|
| Cell Proliferation | 3 | 2016 | 603 | 0.560 |
Why?
|
| Decompression, Surgical | 3 | 2019 | 55 | 0.540 |
Why?
|
| Hearing Aids | 1 | 2017 | 2 | 0.540 |
Why?
|
| Meningitis, Fungal | 1 | 2017 | 1 | 0.520 |
Why?
|
| Ascomycota | 1 | 2017 | 5 | 0.510 |
Why?
|
| Methylprednisolone | 1 | 2017 | 14 | 0.510 |
Why?
|
| Drug Contamination | 1 | 2017 | 6 | 0.510 |
Why?
|
| Abscess | 1 | 2017 | 28 | 0.500 |
Why?
|
| Liposomes | 1 | 2016 | 34 | 0.490 |
Why?
|
| Communication | 1 | 2017 | 128 | 0.490 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2013 | 60 | 0.480 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 112 | 0.480 |
Why?
|
| Nanoparticles | 1 | 2016 | 52 | 0.470 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 231 | 0.470 |
Why?
|
| Monitoring, Intraoperative | 4 | 2009 | 40 | 0.460 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2015 | 2 | 0.450 |
Why?
|
| Chondrosarcoma | 2 | 2014 | 10 | 0.440 |
Why?
|
| Aorta, Thoracic | 1 | 2015 | 81 | 0.420 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2014 | 4 | 0.410 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 37 | 0.410 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 43 | 0.410 |
Why?
|
| Intraoperative Complications | 2 | 2011 | 55 | 0.410 |
Why?
|
| Epidermal Cyst | 1 | 2013 | 4 | 0.400 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2014 | 65 | 0.400 |
Why?
|
| Atlanto-Axial Joint | 2 | 2010 | 3 | 0.400 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2010 | 25 | 0.390 |
Why?
|
| Endoscopy | 2 | 2010 | 54 | 0.390 |
Why?
|
| Vasospasm, Intracranial | 2 | 2010 | 13 | 0.380 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 423 | 0.380 |
Why?
|
| Apoptosis | 1 | 2014 | 375 | 0.360 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 157 | 0.360 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 96 | 0.350 |
Why?
|
| Male | 21 | 2019 | 19443 | 0.340 |
Why?
|
| Disease Models, Animal | 3 | 2011 | 1083 | 0.340 |
Why?
|
| Medical Errors | 1 | 2011 | 34 | 0.340 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2011 | 1 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2014 | 907 | 0.340 |
Why?
|
| Basilar Artery | 1 | 2010 | 9 | 0.330 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2010 | 6 | 0.330 |
Why?
|
| Orthopedic Procedures | 1 | 2011 | 91 | 0.320 |
Why?
|
| Radiosurgery | 2 | 2011 | 355 | 0.320 |
Why?
|
| Spinal Cord Compression | 1 | 2010 | 7 | 0.320 |
Why?
|
| Female | 20 | 2019 | 19947 | 0.320 |
Why?
|
| Middle Aged | 15 | 2019 | 11853 | 0.320 |
Why?
|
| Cervical Atlas | 1 | 2010 | 1 | 0.320 |
Why?
|
| Neurosurgery | 2 | 2018 | 36 | 0.320 |
Why?
|
| Laminectomy | 3 | 2019 | 14 | 0.320 |
Why?
|
| Skull Base | 1 | 2010 | 4 | 0.320 |
Why?
|
| Glioblastoma | 1 | 2011 | 159 | 0.310 |
Why?
|
| Mouth | 1 | 2010 | 23 | 0.310 |
Why?
|
| Occipital Bone | 1 | 2010 | 14 | 0.310 |
Why?
|
| Bone Neoplasms | 1 | 2011 | 117 | 0.310 |
Why?
|
| Neuroendoscopes | 1 | 2009 | 1 | 0.300 |
Why?
|
| Neuroendoscopy | 1 | 2009 | 3 | 0.300 |
Why?
|
| Ependymoma | 1 | 2009 | 4 | 0.300 |
Why?
|
| Joint Instability | 1 | 2010 | 89 | 0.290 |
Why?
|
| Diskectomy | 3 | 2015 | 17 | 0.290 |
Why?
|
| Vertebroplasty | 1 | 2008 | 1 | 0.270 |
Why?
|
| Polymethyl Methacrylate | 1 | 2008 | 11 | 0.270 |
Why?
|
| Aneurysm, Dissecting | 1 | 2008 | 12 | 0.270 |
Why?
|
| Intracranial Aneurysm | 1 | 2008 | 68 | 0.250 |
Why?
|
| Renal Artery Obstruction | 1 | 2006 | 38 | 0.240 |
Why?
|
| Renal Artery | 1 | 2006 | 47 | 0.240 |
Why?
|
| Abdominal Injuries | 1 | 2006 | 32 | 0.240 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 443 | 0.240 |
Why?
|
| Gliosarcoma | 1 | 2005 | 1 | 0.230 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2006 | 88 | 0.230 |
Why?
|
| Postoperative Complications | 5 | 2015 | 823 | 0.230 |
Why?
|
| Neoplasm Invasiveness | 2 | 2016 | 180 | 0.220 |
Why?
|
| Stents | 1 | 2006 | 159 | 0.220 |
Why?
|
| Aged | 12 | 2019 | 10265 | 0.220 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 104 | 0.220 |
Why?
|
| Brain Neoplasms | 2 | 2010 | 637 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2015 | 1224 | 0.190 |
Why?
|
| Sacrum | 2 | 2014 | 18 | 0.190 |
Why?
|
| Spinal Diseases | 2 | 2014 | 21 | 0.190 |
Why?
|
| Combined Modality Therapy | 3 | 2015 | 555 | 0.180 |
Why?
|
| Treatment Outcome | 6 | 2013 | 3416 | 0.180 |
Why?
|
| Hematoma, Subdural | 2 | 2013 | 10 | 0.180 |
Why?
|
| Sarcoma | 2 | 2014 | 92 | 0.180 |
Why?
|
| Signal Transduction | 2 | 2016 | 727 | 0.170 |
Why?
|
| Adult | 7 | 2018 | 9259 | 0.170 |
Why?
|
| Child | 4 | 2013 | 2435 | 0.170 |
Why?
|
| Craniotomy | 2 | 2012 | 38 | 0.160 |
Why?
|
| Radiculopathy | 1 | 2019 | 6 | 0.150 |
Why?
|
| Brain | 2 | 2006 | 965 | 0.150 |
Why?
|
| Spinal Stenosis | 1 | 2019 | 10 | 0.150 |
Why?
|
| Spinal Cord | 2 | 2009 | 137 | 0.140 |
Why?
|
| Hearing Loss | 1 | 2017 | 25 | 0.130 |
Why?
|
| Spinal Cord Injuries | 2 | 2015 | 44 | 0.130 |
Why?
|
| Amphotericin B | 1 | 2017 | 12 | 0.130 |
Why?
|
| Angiography | 2 | 2008 | 76 | 0.130 |
Why?
|
| Antifungal Agents | 1 | 2017 | 45 | 0.130 |
Why?
|
| Protamines | 1 | 2016 | 4 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 65 | 0.120 |
Why?
|
| Animals | 6 | 2011 | 8199 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2017 | 308 | 0.120 |
Why?
|
| Recurrence | 1 | 2017 | 285 | 0.120 |
Why?
|
| Pneumocephalus | 1 | 2015 | 3 | 0.120 |
Why?
|
| Esophageal Perforation | 1 | 2015 | 2 | 0.120 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 3902 | 0.120 |
Why?
|
| DNA | 1 | 2016 | 223 | 0.110 |
Why?
|
| Neurologic Examination | 1 | 2015 | 30 | 0.110 |
Why?
|
| Polymers | 2 | 2005 | 66 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 2240 | 0.110 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 86 | 0.110 |
Why?
|
| Rats | 2 | 2011 | 1895 | 0.110 |
Why?
|
| Hemipelvectomy | 1 | 2014 | 1 | 0.110 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2014 | 5 | 0.110 |
Why?
|
| Rhabdomyosarcoma | 1 | 2014 | 7 | 0.110 |
Why?
|
| Anticoagulants | 2 | 2013 | 122 | 0.110 |
Why?
|
| Neuronavigation | 1 | 2014 | 8 | 0.100 |
Why?
|
| Accidents, Traffic | 2 | 2014 | 204 | 0.100 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2014 | 20 | 0.100 |
Why?
|
| Manikins | 1 | 2014 | 39 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 95 | 0.100 |
Why?
|
| Bone Screws | 1 | 2014 | 55 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 246 | 0.100 |
Why?
|
| Fibroblasts | 1 | 2014 | 119 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2014 | 250 | 0.100 |
Why?
|
| Thromboembolism | 1 | 2013 | 33 | 0.100 |
Why?
|
| Random Allocation | 2 | 2011 | 247 | 0.100 |
Why?
|
| Adolescent | 3 | 2010 | 3519 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 299 | 0.100 |
Why?
|
| Cell Movement | 1 | 2014 | 167 | 0.100 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 46 | 0.100 |
Why?
|
| Hematoma, Subdural, Chronic | 1 | 2012 | 2 | 0.090 |
Why?
|
| Young Adult | 4 | 2015 | 2649 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2014 | 499 | 0.090 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 73 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2014 | 839 | 0.090 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2011 | 7 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2011 | 38 | 0.090 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2011 | 4 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 109 | 0.080 |
Why?
|
| Sciatic Neuropathy | 1 | 2011 | 15 | 0.080 |
Why?
|
| Glioma | 1 | 2012 | 137 | 0.080 |
Why?
|
| Tibia | 1 | 2011 | 56 | 0.080 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2010 | 12 | 0.080 |
Why?
|
| Cell Survival | 1 | 2011 | 288 | 0.080 |
Why?
|
| Retropharyngeal Abscess | 1 | 2010 | 2 | 0.080 |
Why?
|
| Odontoid Process | 1 | 2010 | 2 | 0.080 |
Why?
|
| Internal Fixators | 1 | 2010 | 7 | 0.080 |
Why?
|
| Cerebral Angiography | 1 | 2010 | 60 | 0.080 |
Why?
|
| Injections, Intraventricular | 2 | 2011 | 16 | 0.080 |
Why?
|
| Hematoma, Epidural, Spinal | 1 | 2010 | 2 | 0.080 |
Why?
|
| Pharynx | 1 | 2010 | 13 | 0.080 |
Why?
|
| Multiple Trauma | 1 | 2010 | 41 | 0.080 |
Why?
|
| Gene Expression | 1 | 2011 | 346 | 0.080 |
Why?
|
| Brachial Plexus | 1 | 2010 | 28 | 0.080 |
Why?
|
| Neoplasms, Bone Tissue | 1 | 2009 | 1 | 0.080 |
Why?
|
| Neoplasms, Plasma Cell | 1 | 2009 | 1 | 0.080 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2009 | 2 | 0.080 |
Why?
|
| Giant Cell Tumors | 1 | 2009 | 5 | 0.080 |
Why?
|
| Carcinoma | 1 | 2010 | 92 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 2010 | 85 | 0.080 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2009 | 8 | 0.070 |
Why?
|
| Hemangioma | 1 | 2009 | 23 | 0.070 |
Why?
|
| Epidural Abscess | 1 | 2009 | 4 | 0.070 |
Why?
|
| Radiography | 1 | 2010 | 363 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2009 | 62 | 0.070 |
Why?
|
| Interdisciplinary Communication | 1 | 2009 | 60 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2009 | 74 | 0.070 |
Why?
|
| Central Nervous System | 1 | 2009 | 47 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2009 | 79 | 0.070 |
Why?
|
| Embolization, Therapeutic | 1 | 2009 | 81 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2009 | 105 | 0.070 |
Why?
|
| Delayed-Action Preparations | 2 | 2006 | 33 | 0.070 |
Why?
|
| Disease Management | 1 | 2009 | 129 | 0.070 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2008 | 3 | 0.070 |
Why?
|
| Bone Cements | 1 | 2008 | 10 | 0.070 |
Why?
|
| Radiographic Image Enhancement | 1 | 2008 | 30 | 0.070 |
Why?
|
| Fluoroscopy | 1 | 2008 | 36 | 0.070 |
Why?
|
| Microsurgery | 1 | 2008 | 21 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2014 | 3628 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 298 | 0.070 |
Why?
|
| Cerebral Hemorrhage | 1 | 2008 | 72 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2008 | 72 | 0.060 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2006 | 1 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2010 | 1233 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 395 | 0.060 |
Why?
|
| Polyvinyls | 1 | 2006 | 7 | 0.060 |
Why?
|
| Intracranial Embolism | 1 | 2006 | 15 | 0.060 |
Why?
|
| Cerebral Infarction | 1 | 2006 | 25 | 0.060 |
Why?
|
| Heart Valve Diseases | 1 | 2006 | 28 | 0.060 |
Why?
|
| Ultrasonography, Doppler | 1 | 2006 | 23 | 0.060 |
Why?
|
| Intracranial Hemorrhages | 1 | 2006 | 34 | 0.060 |
Why?
|
| Hematoma | 1 | 2006 | 26 | 0.060 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2006 | 46 | 0.060 |
Why?
|
| Fibrinolytic Agents | 1 | 2006 | 63 | 0.060 |
Why?
|
| Injections, Intralesional | 1 | 2005 | 16 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2005 | 38 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2005 | 66 | 0.060 |
Why?
|
| Microspheres | 1 | 2005 | 45 | 0.060 |
Why?
|
| Mice | 1 | 2011 | 2571 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 164 | 0.060 |
Why?
|
| Rats, Inbred F344 | 1 | 2005 | 151 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2010 | 489 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2006 | 159 | 0.060 |
Why?
|
| Doxorubicin | 1 | 2005 | 76 | 0.060 |
Why?
|
| Nitric Oxide Donors | 1 | 2004 | 8 | 0.060 |
Why?
|
| Anesthesia, Conduction | 1 | 2004 | 24 | 0.050 |
Why?
|
| Anesthesia, General | 1 | 2004 | 30 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 762 | 0.050 |
Why?
|
| Rabbits | 3 | 2011 | 219 | 0.050 |
Why?
|
| Survival Rate | 1 | 2005 | 893 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 312 | 0.050 |
Why?
|
| Prognosis | 1 | 2006 | 1534 | 0.050 |
Why?
|
| Range of Motion, Articular | 2 | 2014 | 196 | 0.050 |
Why?
|
| Stroke | 1 | 2008 | 691 | 0.040 |
Why?
|
| Atrophy | 2 | 2012 | 46 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2004 | 349 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 504 | 0.040 |
Why?
|
| Length of Stay | 2 | 2012 | 321 | 0.040 |
Why?
|
| Low Back Pain | 1 | 2019 | 43 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2019 | 165 | 0.040 |
Why?
|
| Leg | 1 | 2019 | 69 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 456 | 0.030 |
Why?
|
| Developing Countries | 1 | 2018 | 57 | 0.030 |
Why?
|
| Reoperation | 1 | 2019 | 252 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2019 | 341 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2014 | 1479 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 657 | 0.030 |
Why?
|
| Pain | 1 | 2019 | 304 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 242 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2014 | 85 | 0.030 |
Why?
|
| Automobiles | 1 | 2014 | 19 | 0.030 |
Why?
|
| Air Bags | 1 | 2014 | 15 | 0.030 |
Why?
|
| Arthroplasty | 1 | 2014 | 28 | 0.030 |
Why?
|
| Neck | 1 | 2014 | 32 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 89 | 0.030 |
Why?
|
| Enoxaparin | 1 | 2013 | 13 | 0.020 |
Why?
|
| Warfarin | 1 | 2013 | 32 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 132 | 0.020 |
Why?
|
| Morbidity | 1 | 2013 | 98 | 0.020 |
Why?
|
| Aspirin | 1 | 2013 | 59 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2013 | 79 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2012 | 26 | 0.020 |
Why?
|
| Pressure | 1 | 2012 | 69 | 0.020 |
Why?
|
| Rotation | 1 | 2012 | 51 | 0.020 |
Why?
|
| Drainage | 1 | 2012 | 65 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2013 | 204 | 0.020 |
Why?
|
| Sacrococcygeal Region | 1 | 2011 | 6 | 0.020 |
Why?
|
| Cadaver | 1 | 2012 | 151 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 2011 | 11 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2012 | 55 | 0.020 |
Why?
|
| Cisterna Magna | 1 | 2011 | 1 | 0.020 |
Why?
|
| Survival | 1 | 2011 | 13 | 0.020 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2011 | 13 | 0.020 |
Why?
|
| Injections | 1 | 2011 | 72 | 0.020 |
Why?
|
| Injections, Spinal | 1 | 2011 | 119 | 0.020 |
Why?
|
| Osteotomy | 1 | 2011 | 55 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 388 | 0.020 |
Why?
|
| Tibial Nerve | 1 | 2011 | 19 | 0.020 |
Why?
|
| Anesthesia | 1 | 2011 | 63 | 0.020 |
Why?
|
| Sural Nerve | 1 | 2011 | 25 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 113 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 252 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2010 | 110 | 0.020 |
Why?
|
| Executive Function | 1 | 2010 | 52 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2010 | 75 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 70 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2009 | 11 | 0.020 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2011 | 191 | 0.020 |
Why?
|
| Ventriculostomy | 1 | 2009 | 10 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2009 | 43 | 0.020 |
Why?
|
| Jugular Veins | 1 | 2009 | 24 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2011 | 320 | 0.020 |
Why?
|
| Registries | 1 | 2010 | 294 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 2010 | 142 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 520 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 1010 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2006 | 13 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 393 | 0.020 |
Why?
|
| Cerebral Veins | 1 | 2006 | 11 | 0.020 |
Why?
|
| Heart Valves | 1 | 2006 | 16 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2006 | 15 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 2006 | 11 | 0.020 |
Why?
|
| Intracranial Hypertension | 1 | 2006 | 19 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2006 | 63 | 0.020 |
Why?
|
| Echocardiography | 1 | 2006 | 190 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 3934 | 0.010 |
Why?
|
| Drug Implants | 1 | 2004 | 10 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 276 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 95 | 0.010 |
Why?
|
| Analgesia, Epidural | 1 | 2004 | 48 | 0.010 |
Why?
|
| United States | 1 | 2010 | 4072 | 0.010 |
Why?
|